Navigation Links
Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
Date:4/16/2012

By Kathleen Doheny
HealthDay Reporter

MONDAY, April 16 (HealthDay News) -- A bariatric surgical procedure is more likely than medicine to improve or even reverse type 2 diabetes in very obese patients, a new small study indicates.

Italian researchers compared standard diabetes medicine with a surgical procedure known as the laparoscopic sleeve gastrectomy, and while 80 percent of those treated with the surgery had remission of their diabetes within 18 months, none of those treated with medicine did.

"In our opinion, 80 percent diabetes resolution is a dramatically excellent result, compared with results of a medical approach in which there's not diabetes resolution," said lead researcher Dr. Nicola Basso, a professor of surgery at the University of Rome, Sapienza.

All of those who had surgery and had diabetes less than 10 years reversed it, Basso said.

The study appeared online April 16 in the Archives of Surgery.

In the procedure, doctors remove about 85 percent of the stomach and shape the remaining portion into a tube or sleeve. Fewer calories can be eaten, and weight loss is the result.

"At present, we think that sleeve gastrectomy may be considered the surgical procedure of choice in treating 'diabesity,'" said Basso.

The researchers assigned 30 patients to the surgery group and another 30 to the medicine group. All had a body-mass index (BMI) of 35 or higher. With BMI, which takes both height and weight into account, 30 is the beginning of the obese category.

A person who is 5-foot-10 and weighs 250 pounds has a BMI of nearly 36.

Basso's team followed the patients for 18 months to see what effect the treatments had on their diabetes and other health measures.

The surgery group's average BMI went from 41 to about 28. The medicine group's BMI, 39 on average at the start, went up slightly.

Those who had the surgery had improvements in other areas. Sleep apnea dropped from 50 percent to 10 percent. After surgery, patients reduced their use of medicine for high blood pressure and cholesterol problems.

None in the medicine group reversed their diabetes. Their need for high blood pressure medicine and cholesterol medicines increased, although not significantly. Their sleep apnea did not change.

The study results are not surprising, said Dr. Ronald Goldberg, a professor of medicine at the Diabetes Research Institute at the University of Miami Miller School of Medicine.

"It's fairly in line with previous research using different bypass procedures," he said.

The latest findings could be very good news for very obese patients with diabetes, he said.

"The milder type is much more likely to go into remission than someone who has longstanding or complicated diabetes," he said. The procedure is worth consideration by someone who is very obese and has type 2 diabetes, he added.

The cost of the procedure in the United States is between $10,000 and $15,000.

"There is no question that over the short term, surgery has to be more expensive," Goldberg said. "But with time, the increased cost of managing diabetes, and particularly its complications, would make a cost-benefit comparison more meaningful."

More information

To learn more about diabetes, visit the American Diabetes Association.

SOURCES: Nicola Basso, M.D., Ph.D., professor, surgery, University of Rome, Sapienza; Ronald Goldberg, M.D, endocrinologist and professor, medicine, University of Miami Miller School of Medicine; April 16, 2012, Archives of Surgery, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Weight-Loss Surgeries May Beat Standard Treatments for Diabetes
2. Weight-Loss Surgery Seems Safe for Kidney Disease Patients
3. Mid-morning snacking may sabotage weight-loss efforts
4. Weighing Weight-Loss Programs
5. Weight Watchers Produces Bigger Losers Than Standard Weight-Loss Care
6. U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall
7. Weight-Loss Surgery Gains More Practitioners
8. Rigorous Exercise May Boost Benefits of Weight-Loss Surgery
9. Weight-loss surgery cost-effective for all obese
10. Weight-Loss Surgery Helps Less Obese Patients: Study
11. Can Weight-Loss Surgery Reverse Common Cause of Infertility?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER ... ensure lab personnel have a basic understanding of the techniques they use so ... understanding will help them reduce waste and rework to create a leaner overall ...
(Date:2/9/2016)... Santa Rosa, California (PRWEB) , ... February 09, 2016 , ... ... been rated one of the highest preliminary data vendors in the latest KLAS report, ... 15 years, i2i has led the developing market for population health management (PHM). ...
(Date:2/8/2016)... Bethlehem, PA (PRWEB) , ... February 08, 2016 ... ... announce expanded authorization with BASF Human Nutrition into the Food & Beverage ... BSI has been BASF’s channel partner throughout Canada and USA geographies east ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... packer for pouches, bags, and flow wrapped products at WestPack 2015, February 9-11, ... product manufacturers step up to semi-automatic or fully-automatic case packing with a small ...
(Date:2/8/2016)... Venice, FL (PRWEB) , ... February 08, 2016 ... ... their new community enrichment program serving the greater Venice, FL area, has initiated ... died tragically in a car accident just four days after Christmas. To support ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, today announced financial ... half of fiscal year 2016 ended December 31, ... --> Highlights for the second quarter and ...
(Date:2/9/2016)... YORK, Pa., Feb. 9, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced its financial results for ... 2015). ... Revenue for the ... million in the same period last year.  Cash receipts from customers ...
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
Breaking Medicine Technology: